Prosthetic Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Prosthetic Heart Valves Pipeline Market Report Overview

Prosthetic heart valves is a device which mimics the function of human heart valves and have a passive mode of functioning; opening and closing of valves are responses to pressure and flow changes within the heart. They are for the patients that have a heart valvular disease where they need their valve to be replaced.

The Prosthetic Heart Valves pipeline market research report provides comprehensive information about the Prosthetic Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Prosthetic Heart Valves Pipeline Market Segments

The key segments in the Prosthetic Heart Valves pipeline market are Tissue Heart Valves, Transcatheter valve delivery devices, Mechanical Heart Valves, Tissue Sutureless Aortic Valve Replacements, Tissue Sutured Mitral Valve Replacements, Mechanical Sutured Mitral Valve Replacements, and Tissue Sutured Aortic Valve Replacements. As of April 2023, Tissue Heart Valves has the highest number of pipeline products.

Tissue Heart Valves: They are a combination of tissue and synthetic biomaterials with the tissue itself being flexible. Bovine and porcine valves are included here. This segment comprises of Tissue Sutured Mitral Valve Replacements, Tissue Sutureless Aortic Valve Replacements and Tissue Sutured Aortic Valve Replacements.

Prosthetic Heart Valves Pipeline Market Analysis, by Segments, 2023 (%)

Prosthetic Heart Valves Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the Prosthetic Heart Valves pipeline market, download a free report sample

Prosthetic Heart Valves Pipeline Market Segmentation by Territories

Some of the key territories in the Prosthetic Heart Valves pipeline market are the US, Europe, China, India, Israel, Japan, Canada, Singapore, South Korea, and Taiwan. As of April 2023, the US has the highest number of pipeline products.

Prosthetic Heart Valves Pipeline Market Analysis, by Territories, 2023 (%)

Prosthetic Heart Valves Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the Prosthetic Heart Valves pipeline market, download a free report sample

Prosthetic Heart Valves Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Prosthetic Heart Valves pipeline market are PMA, CE, NMPA, 510(k), HDE Approvals, ICAC, MDL, Shonin, NIFDS, and HAS. As of April 2023, PMA is the most followed pathway for pipeline products.

Prosthetic Heart Valves Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Prosthetic Heart Valves Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory paths into the Prosthetic Heart Valves pipeline market, download a free report sample

Prosthetic Heart Valves Pipeline Market - Competitive Landscape

Some of the key companies in the Prosthetic Heart Valves pipeline market are AGEless Biomedical Inc, Anchorvalve, Anteris Technologies Ltd, Artivion Inc, Autus Valve Technologies Inc, Biostage Inc, Boston Children’s Hospital, Colibri Heart Valve LLC, Collagen Solutions Ltd, and Collplant Biotechnologies Ltd.

Anteris Technologies Ltd- Headquartered in Brisbane, Queensland, Australia, Anteris Technologies Ltd, (Anteris Technologies), formerly Admedus Ltd develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. The company’s product portfolio includes ADAPT technology, a next generation bio scaffold that reengineers xenograft tissue into a pure collagen scaffold and DurAVR heart valve, a 3D single piece aortic valve that creates a wider valve opening and better blood flow.

Artivion Inc- Headquartered in Atlanta, Georgia, the US, Artivion Inc (Artivion), formerly CryoLife Inc, is a medical device company that manufactures and distributes biosurgical devices and implantable human tissues for cardiac and vascular surgical procedures for the treatment of aortic disease. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, bovine pericardium, and mitral chordal repair products, photofix products and Jotec products. The company products serve physicians, cardiac surgeons, hospitals, and medical institutions.

Biostage Inc- Headquartered in Holliston, Massachusetts, the US, Biostage Inc (Biostage) operates as a biotechnology company. The company carries out the business of development and commercialization of regenerated organs for human transplant. It develops bioengineered organ implants based on its Cellframe technology which combines biocompatible scaffold with a patient’s own stem cells to create Cellspan organ implants. Biostage’s pipeline offerings include Cellspan bronchial implants, Cellspan esophageal implants and Cellspan tracheal implants. The company has operations across Germany, the US, Sweden and the UK.

Prosthetic Heart Valves Pipeline Market Report Overview

Key Territories The US, Europe, China, India, Israel, Japan, Canada, Singapore, South Korea, and Taiwan
Key Segments Tissue Heart Valves, Transcatheter valve delivery devices, Mechanical Heart Valves, Tissue Sutureless Aortic Valve Replacements, Tissue Sutured Mitral Valve Replacements, Mechanical Sutured Mitral Valve Replacements, and Tissue Sutured Aortic Valve Replacements
Key Regulatory Paths PMA, CE, NMPA, 510(k), HDE Approvals, ICAC, MDL, Shonin, NIFDS, HAS, and BOPA
Leading Companies AGEless Biomedical Inc, Anchorvalve, Anteris Technologies Ltd, Artivion Inc, Autus Valve Technologies Inc, Biostage Inc, Boston Children’s Hospital, Colibri Heart Valve LLC, Collagen Solutions Ltd, and Collplant Biotechnologies Ltd

Segments Covered in the Report

Prosthetic Heart Valves Pipeline Market Segments Outlook

  • Tissue Heart Valves
  • Transcatheter valve delivery devices
  • Mechanical Heart Valves
  • Tissue Sutureless Aortic Valve Replacements
  • Tissue Sutured Mitral Valve Replacements
  • Mechanical Sutured Mitral Valve Replacements
  • Tissue Sutured Aortic Valve Replacements

Prosthetic Heart Valves Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • India
  • Israel
  • Japan
  • Canada
  • Singapore
  • South Korea
  • Taiwan

Prosthetic Heart Valves Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • 510(k)
  • HDE Approvals
  • ICAC
  • MDL
  • Shonin
  • NIFDS
  • HAS
  • BOPA

Scope

  • Extensive coverage of the Prosthetic Heart Valves under development
  • Reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • Reviews the major players involved in the development of Prosthetic Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • Provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Prosthetic Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

AGEless Biomedical Inc
Anchorvalve
Anteris Technologies Ltd
Artivion Inc
Autus Valve Technologies Inc
Biostage Inc
Boston Children's Hospital
Colibri Heart Valve LLC
Collagen Solutions Ltd
Collplant Biotechnologies Ltd
Colorado State University
Columbia University
CorMatrix Cardiovascular Inc
CroiValve Ltd
Cytograft Tissue Engineering Inc (Inactive)
Daidalos Solutions BV
Department of Biomedical Engineering Columbia University
Edwards Lifesciences Corp
Enlight Medical Technologies (Shanghai) Co Ltd
enVVeno Medical Corp
Florida International University
FluidForm Inc
Foldax Inc
Georgia Institute of Technology
Griffith University
Hocor Cardiovascular Technologies, LLC
Innovator Lab Consultants India Pvt Ltd
Innovia LLC
InspireMD Inc
JC Medical, Inc.
Jinshi Biotechnology (Changshu) Co Ltd
Leman Cardiovascular SA
Lifelet Medical Ltd
Medi-Line S.A.
Medtronic Plc
Meril Life Sciences Pvt Ltd
MicroPort Scientific Corp
National University of Singapore
NaviGate Cardiac Structures, Inc.
NewMed Medical Co Ltd
On-X Life Technologies Inc
Peca Labs Inc
Rambam Health Care Campus
Revivicor Inc
Shanghai Aoliu Medical Technology Co Ltd
Shanghai Hanyu Medical Technology Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Stellenbosch University
Symetis SA
The Charles Stark Draper Laboratory Inc
Thoratec LLC
Thubrikar Aortic Valve, Inc.
TRiCares SAS
TTK Healthcare Ltd
University College London
University of Arizona
University of California
University of California Irvine
University of Cambridge
University of Colorado
University of Florida
University of Nebraska
University of Pennsylvania
University of Pittsburgh Medical Center
University of South Florida
University of Zurich
ValveXchange, Inc. (Inactive)
Vdyne LLC
Venus Haoyue Medtech Ltd
Venus Medtech Hangzhou Inc
VueKlar Cardiovascular Ltd (Inactive)
W. L. Gore & Associates Inc
Xeltis AG

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 14

2 Introduction 15

2.1 Prosthetic Heart Valves Overview 15

3 Products under Development 16

3.1 Prosthetic Heart Valves – Pipeline Products by Stage of Development 16

3.2 Prosthetic Heart Valves – Pipeline Products by Segment 17

3.3 Prosthetic Heart Valves – Pipeline Products by Territory 18

3.4 Prosthetic Heart Valves – Pipeline Products by Regulatory Path 19

3.5 Prosthetic Heart Valves – Pipeline Products by Estimated Approval Date 20

3.6 Prosthetic Heart Valves – Ongoing Clinical Trials 21

4 Prosthetic Heart Valves – Pipeline Products under Development by Companies 22

4.1 Prosthetic Heart Valves Companies – Pipeline Products by Stage of Development 22

4.2 Prosthetic Heart Valves – Pipeline Products by Stage of Development 25

5 Prosthetic Heart Valves Companies and Product Overview 29

5.1 AGEless Biomedical Inc Company Overview 29

5.1.1 AGEless Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.2 Anchorvalve Company Overview 30

5.2.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview 30

5.3 Anteris Technologies Ltd Company Overview 32

5.3.1 Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.4 Artivion Inc Company Overview 37

5.4.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.5 Autus Valve Technologies Inc Company Overview 44

5.5.1 Autus Valve Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.6 Biostage Inc Company Overview 47

5.6.1 Biostage Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.7 Boston Children’s Hospital Company Overview 48

5.7.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 48

5.8 Colibri Heart Valve LLC Company Overview 50

5.8.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 50

5.9 Collagen Solutions Ltd Company Overview 53

5.9.1 Collagen Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

5.10 Collplant Biotechnologies Ltd Company Overview 54

5.10.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.11 Colorado State University Company Overview 55

5.11.1 Colorado State University Pipeline Products & Ongoing Clinical Trials Overview 55

5.12 Columbia University Company Overview 56

5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 56

5.13 CorMatrix Cardiovascular Inc Company Overview 57

5.13.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.14 CroiValve Ltd Company Overview 64

5.14.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.15 Cytograft Tissue Engineering Inc (Inactive) Company Overview 67

5.15.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67

5.16 Daidalos Solutions BV Company Overview 68

5.16.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 68

5.17 Department of Biomedical Engineering Columbia University Company Overview 69

5.17.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 69

5.18 Edwards Lifesciences Corp Company Overview 70

5.18.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 70

5.19 Enlight Medical Technologies (Shanghai) Co Ltd Company Overview 73

5.19.1 Enlight Medical Technologies (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

5.20 enVVeno Medical Corp Company Overview 74

5.20.1 enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 74

5.21 Florida International University Company Overview 76

5.21.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 FluidForm Inc Company Overview 77

5.22.1 FluidForm Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.23 Foldax Inc Company Overview 78

5.23.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 Georgia Institute of Technology Company Overview 79

5.24.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 79

5.25 Griffith University Company Overview 80

5.25.1 Griffith University Pipeline Products & Ongoing Clinical Trials Overview 80

5.26 Hocor Cardiovascular Technologies, LLC Company Overview 81

5.26.1 Hocor Cardiovascular Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 81

5.27 Innovator Lab Consultants India Pvt Ltd Company Overview 82

5.27.1 Innovator Lab Consultants India Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 82

5.28 Innovia LLC Company Overview 83

5.28.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 83

5.29 InspireMD Inc Company Overview 85

5.29.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.30 JC Medical, Inc. Company Overview 87

5.30.1 JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87

5.31 Jinshi Biotechnology (Changshu) Co Ltd Company Overview 90

5.31.1 Jinshi Biotechnology (Changshu) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.32 Leman Cardiovascular SA Company Overview 91

5.32.1 Leman Cardiovascular SA Pipeline Products & Ongoing Clinical Trials Overview 91

5.33 Lifelet Medical Ltd Company Overview 92

5.33.1 Lifelet Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

5.34 Medi-Line S.A. Company Overview 93

5.34.1 Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview 93

5.35 Medtronic Plc Company Overview 94

5.35.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 94

5.36 Meril Life Sciences Pvt Ltd Company Overview 96

5.36.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

5.37 MicroPort Scientific Corp Company Overview 103

5.37.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 103

5.38 National University of Singapore Company Overview 104

5.38.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 104

5.39 NaviGate Cardiac Structures, Inc. Company Overview 105

5.39.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105

5.40 NewMed Medical Co Ltd Company Overview 106

5.40.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

5.41 On-X Life Technologies Inc Company Overview 110

5.41.1 On-X Life Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 110

5.42 Peca Labs Inc Company Overview 112

5.42.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 112

5.43 Rambam Health Care Campus Company Overview 115

5.43.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 115

5.44 Revivicor Inc Company Overview 116

5.44.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.45 Shanghai Aoliu Medical Technology Co Ltd Company Overview 117

5.45.1 Shanghai Aoliu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 117

5.46 Shanghai Hanyu Medical Technology Co Ltd Company Overview 118

5.46.1 Shanghai Hanyu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 118

5.47 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 119

5.47.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 119

5.48 St. Jude Medical LLC Company Overview 121

5.48.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 121

5.49 Stellenbosch University Company Overview 124

5.49.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 124

5.50 Symetis SA Company Overview 125

5.50.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview 125

5.51 The Charles Stark Draper Laboratory Inc Company Overview 126

5.51.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.52 Thoratec LLC Company Overview 129

5.52.1 Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 129

5.53 Thubrikar Aortic Valve, Inc. Company Overview 130

5.53.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130

5.54 TRiCares SAS Company Overview 132

5.54.1 TRiCares SAS Pipeline Products & Ongoing Clinical Trials Overview 132

5.55 TTK Healthcare Ltd Company Overview 135

5.55.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 135

5.56 University College London Company Overview 136

5.56.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 136

5.57 University of Arizona Company Overview 137

5.57.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 137

5.58 University of California Company Overview 138

5.58.1 University of California Pipeline Products & Ongoing Clinical Trials Overview 138

5.59 University of California Irvine Company Overview 139

5.59.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 139

5.60 University of Cambridge Company Overview 142

5.60.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 142

5.61 University of Colorado Company Overview 143

5.61.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 143

5.62 University of Florida Company Overview 144

5.62.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 144

5.63 University of Nebraska Company Overview 145

5.63.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 145

5.64 University of Pennsylvania Company Overview 146

5.64.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 146

5.65 University of Pittsburgh Medical Center Company Overview 149

5.65.1 University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview 149

5.66 University of South Florida Company Overview 150

5.66.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 150

5.67 University of Zurich Company Overview 151

5.67.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 151

5.68 ValveXchange, Inc. (Inactive) Company Overview 152

5.68.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 152

5.69 Vdyne LLC Company Overview 155

5.69.1 Vdyne LLC Pipeline Products & Ongoing Clinical Trials Overview 155

5.70 Venus Haoyue Medtech Ltd Company Overview 158

5.70.1 Venus Haoyue Medtech Ltd Pipeline Products & Ongoing Clinical Trials Overview 158

5.71 Venus Medtech Hangzhou Inc Company Overview 159

5.71.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview 159

5.72 VueKlar Cardiovascular Ltd (Inactive) Company Overview 160

5.72.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 160

5.73 W. L. Gore & Associates Inc Company Overview 161

5.73.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 161

5.74 Xeltis AG Company Overview 162

5.74.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 162

6 Prosthetic Heart Valves- Recent Developments 165

6.1 Apr 05, 2023: JenaValve Appoints Ken MacLeod, Ph.D. to Board of Directors 165

6.2 Mar 21, 2023: Tissue Regenix Group Announces Final results for the year ended 31 December 2022 165

6.3 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 167

6.4 Feb 07, 2023: TTK Healthcare Announces Statement of Unaudited Financial Results for the Quarter and Period Ended 31st December, 2022 167

6.5 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022 168

6.6 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president 169

6.7 Jan 17, 2023: New electromagnetic device could catapult advances in mechanobiology research into the clinical arena 169

6.8 Jan 06, 2023: JenaValve Appoints Dan Dearen to Board of Directors 170

6.9 Dec 12, 2022: RUA Life Sciences confirms half-year loss and revenue 170

6.10 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 170

6.11 Dec 07, 2022: SIH announces that 76 leadership positions will be eliminated, reorganized 171

6.12 Nov 23, 2022: Medtronic Reports Quarterly Earnings 171

6.13 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 171

6.14 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 177

6.15 Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022 177

6.16 Sep 29, 2022: Artivion AORT Appoints Elizabeth Hoff to its Board 177

6.17 Sep 07, 2022: Medtronic to appear at September investor conferences 178

6.18 Sep 07, 2022: Tissue Regenix Group Announces Half-year Report 178

6.19 Aug 25, 2022: Atrion Announces CFO Succession Plan 179

6.20 Aug 24, 2022: Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase 179

6.21 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 179

6.22 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 182

6.23 Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022 185

6.24 Jun 28, 2022: Japan Lifeline Co. Notice of Resolution of the 42nd Annual General Meeting of Shareholders 185

6.25 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 186

6.26 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 187

6.27 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 187

6.28 May 23, 2022: Edwards Lifesciences to Present at the Bernstein 38th Annual Strategic Decisions Conference 187

6.29 May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share 187

6.30 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results 187

6.31 Apr 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on April 26, 2022 188

7 Appendix 189

7.1 Methodology 189

7.2 About GlobalData 192

7.3 Contact Us 192

7.4 Disclaimer 192

Table

Prosthetic Heart Valves – Pipeline Products by Stage of Development 16

Prosthetic Heart Valves – Pipeline Products by Segment 17

Prosthetic Heart Valves – Pipeline Products by Territory 18

Prosthetic Heart Valves – Pipeline Products by Regulatory Path 19

Prosthetic Heart Valves – Pipeline Products by Estimated Approval Date 20

Prosthetic Heart Valves – Ongoing Clinical Trials 21

Prosthetic Heart Valves Companies – Pipeline Products by Stage of Development 22

Prosthetic Heart Valves – Pipeline Products by Stage of Development 25

AGEless Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 29

AGEless Valve – Product Status 29

AGEless Valve – Product Description 29

Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview 30

Sutureless Mitral Valve Prostheses – Product Status 30

Sutureless Mitral Valve Prostheses – Product Description 30

Sutureless Tricuspid Valve Prostheses – Product Status 31

Sutureless Tricuspid Valve Prostheses – Product Description 31

Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

ComASUR Transfemoral Delivery System – Product Status 32

ComASUR Transfemoral Delivery System – Product Description 32

DurAVR Heart Valve – Product Status 33

DurAVR Heart Valve – Product Description 33

DurAVR Leaflet Repair (RP) – Product Status 33

DurAVR Leaflet Repair (RP) – Product Description 34

Anteris Technologies Ltd – Ongoing Clinical Trials Overview 35

DurAVR Heart Valve – First in Human Surgical Implantation of Single Piece ADAPT Treated 3D ALR (Aortic Leaflet Repair), Feasibility and Clinical Safety Study 36

Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Antyllus – Product Status 37

Antyllus – Product Description 38

Aortiger – Product Status 38

Aortiger – Product Description 38

Artivion – Product Status 38

Artivion – Product Description 39

CryoValve SGAV – Product Status 39

CryoValve SGAV – Product Description 39

On-X Mechanical Aortic Valve – ELIQUIS – Product Status 40

On-X Mechanical Aortic Valve – ELIQUIS – Product Description 40

Sanevo – Product Status 40

Sanevo – Product Description 40

Semtis – Product Status 41

Semtis – Product Description 41

Synergraft Xenograft Heart Valve – Product Status 41

Synergraft Xenograft Heart Valve – Product Description 41

Artivion Inc – Ongoing Clinical Trials Overview 42

On-X Mechanical Aortic Valve – ELIQUIS – A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants with an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban 43

Autus Valve Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Autus Size-Adaptable Valve – Product Status 44

Autus Size-Adaptable Valve – Product Description 44

Autus Valve Technologies Inc – Ongoing Clinical Trials Overview 45

Autus Size-Adaptable Valve – Autus Size-Adjustable Valve for Surgical Pulmonary Valve Replacement Early Feasibility Study 46

Biostage Inc Pipeline Products & Ongoing Clinical Trials Overview 47

3D Printed Heart Valve – Product Status 47

3D Printed Heart Valve – Product Description 47

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 48

Heart Valve Leaflet – Product Status 48

Heart Valve Leaflet – Product Description 48

Prosthetic Heart Valve – Product Status 49

Prosthetic Heart Valve – Product Description 49

Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 50

Custom Delivery System – Product Status 50

Custom Delivery System – Product Description 50

Pulmonary Valve – Product Status 51

Pulmonary Valve – Product Description 51

Sutureless Surgical Aortic Valve – Product Status 51

Sutureless Surgical Aortic Valve – Product Description 52

Collagen Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

Heart Valve Device – Product Status 53

Heart Valve Device – Product Description 53

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

3D Printed Heart Valve Tissue – Product Status 54

3D Printed Heart Valve Tissue – Product Description 54

Colorado State University Pipeline Products & Ongoing Clinical Trials Overview 55

BioPoly Heart Valve – Product Status 55

BioPoly Heart Valve – Product Description 55

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 56

Prosthetic Heart Valve – Product Status 56

Prosthetic Heart Valve – Product Description 56

CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Cor PEDIATRIC Tricuspid ECM Valve – Product Status 57

Cor PEDIATRIC Tricuspid ECM Valve – Product Description 57

CorMatrix Cor TRICUSPID ECM Valve Device – Product Status 58

CorMatrix Cor TRICUSPID ECM Valve Device – Product Description 58

CorMatrix ECM – Heart Valve Repair – Product Status 58

CorMatrix ECM – Heart Valve Repair – Product Description 59

CorMatrix ECM – Heart Valve Replacement – Product Status 59

CorMatrix ECM – Heart Valve Replacement – Product Description 59

Regenerating Tubular Mitral Valve – Product Status 60

Regenerating Tubular Mitral Valve – Product Description 60

CorMatrix Cardiovascular Inc – Ongoing Clinical Trials Overview 61

Cor PEDIATRIC Tricuspid ECM Valve – CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility 62

CorMatrix Cor TRICUSPID ECM Valve Device – CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility 63

CorMatrix Cor TRICUSPID ECM Valve Device – CorMatrix Cor TRICUSPID ECM Valve Replacement Study 63

CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Duo Tricuspid Coaptation Valve – Product Status 64

Duo Tricuspid Coaptation Valve – Product Description 64

CroiValve Ltd – Ongoing Clinical Trials Overview 65

Duo Tricuspid Coaptation Valve – A European Feasibility Study of the CroiValve DUO Transcatheter Tricuspid Coaptation Valve System in Patients with Tricuspid Regurgitation 66

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67

Cytograft Valve – Product Status 67

Cytograft Valve – Product Description 67

Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 68

Sutureless Aortic Valve Prosthesis – Product Status 68

Sutureless Aortic Valve Prosthesis – Product Description 68

Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 69

GEVI – Product Status 69

GEVI – Product Description 69

Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 70

Carpentier-Edwards BioPhysio Aortic Valve – Product Status 70

Carpentier-Edwards BioPhysio Aortic Valve – Product Description 70

GLX Aortic Conduit – Product Status 71

GLX Aortic Conduit – Product Description 71

Magna Ease Surgical Valve With GLX – Product Status 71

Magna Ease Surgical Valve With GLX – Product Description 72

Next Generation Mitral Heart Valve – Product Status 72

Next Generation Mitral Heart Valve – Product Description 72

Enlight Medical Technologies (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

Mitral Valve Replacement System – Product Status 73

Mitral Valve Replacement System – Product Description 73

enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 74

Bioprosthetic Aortic Heart Valve – Product Status 74

Bioprosthetic Aortic Heart Valve – Product Description 74

Bioprosthetic Mitral Heart Valve – Product Status 75

Bioprosthetic Mitral Heart Valve – Product Description 75

Florida International University Pipeline Products & Ongoing Clinical Trials Overview 76

Percutaneous Heart Valve Delivery System – Product Status 76

Percutaneous Heart Valve Delivery System – Product Description 76

FluidForm Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Bioprosthetic Collagen Heart Valve – Product Status 77

Bioprosthetic Collagen Heart Valve – Product Description 77

Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview 78

Tria Surgical Tricuspid Heart Valve – Product Status 78

Tria Surgical Tricuspid Heart Valve – Product Description 78

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 79

Replaceable Heart Valve Prosthesis – Product Status 79

Replaceable Heart Valve Prosthesis – Product Description 79

Griffith University Pipeline Products & Ongoing Clinical Trials Overview 80

Next Generation Heart Valve – Product Status 80

Next Generation Heart Valve – Product Description 80

Hocor Cardiovascular Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 81

HOCOR System – Product Status 81

HOCOR System – Product Description 81

Innovator Lab Consultants India Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 82

Mechanical Heart Valve 2.0 – Product Status 82

Mechanical Heart Valve 2.0 – Product Description 82

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 83

Minimally Invasive Synthetic Tri – Leaflet Heart Valve – Product Status 83

Minimally Invasive Synthetic Tri – Leaflet Heart Valve – Product Description 83

Percutaneous Synthetic Tri – Leaflet Heart Valve – Product Status 84

Percutaneous Synthetic Tri – Leaflet Heart Valve – Product Description 84

Sutured In Synthetic Tri – Leaflet Heart Valve – Product Status 84

Sutured In Synthetic Tri – Leaflet Heart Valve – Product Description 84

InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 85

CGuard Prime – Product Status 85

CGuard Prime – Product Description 85

Delivery System – Product Status 86

Delivery System – Product Description 86

JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87

J-Valve TF Delivery System – Product Status 87

J-Valve TF Delivery System – Product Description 87

JC Medical, Inc. – Ongoing Clinical Trials Overview 88

J-Valve TF Delivery System – Efficacy and Safety of the J-Valve Transcatheter Aortic Valve Replacement System in Patients With Aortic Stenosis Disease 89

Jinshi Biotechnology (Changshu) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

Xinli Bioprosthetic Heart Valve – Product Status 90

Xinli Bioprosthetic Heart Valve – Product Description 90

Leman Cardiovascular SA Pipeline Products & Ongoing Clinical Trials Overview 91

Kalangos Valve – Product Status 91

Kalangos Valve – Product Description 91

Lifelet Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

Lifelet Polymer Valve – Product Status 92

Lifelet Polymer Valve – Product Description 92

Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview 93

AVATAR² Device – Product Status 93

AVATAR² Device – Product Description 93

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 94

Closed-Chest Aortic Tissue Valve – Product Status 94

Closed-Chest Aortic Tissue Valve – Product Description 94

Enable Valve – Beating Heart Procedure – Product Status 95

Enable Valve – Beating Heart Procedure – Product Description 95

Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

Daffodil AV – Product Status 96

Daffodil AV – Product Description 97

Daffodil MV – Product Status 97

Daffodil MV – Product Description 97

Dafodil DRI – Product Status 97

Dafodil DRI – Product Description 98

Miltonia-UNO – Product Status 98

Miltonia-UNO – Product Description 98

MyVal 2 – Product Status 98

MyVal 2 – Product Description 99

MyVal Genesis – Product Status 99

MyVal Genesis – Product Description 99

MyVal Hexa – Product Status 99

MyVal Hexa – Product Description 100

MyVal Integra – Product Status 100

MyVal Integra – Product Description 100

Myval Rondevu – Product Status 100

Myval Rondevu – Product Description 101

Navigator 2 – Product Status 101

Navigator 2 – Product Description 101

Navigator Neo – Product Status 101

Navigator Neo – Product Description 102

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 103

Biomaterial Replacement Heart Valve – Product Status 103

Biomaterial Replacement Heart Valve – Product Description 103

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 104

SingValve – Product Status 104

SingValve – Product Description 104

NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105

Trans Femoral Delivery System – Product Status 105

Trans Femoral Delivery System – Product Description 105

NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

ValveClip-M – Product Status 106

ValveClip-M – Product Description 106

ValveClip-T – Product Status 107

ValveClip-T – Product Description 107

NewMed Medical Co Ltd – Ongoing Clinical Trials Overview 108

ValveClip-M – Evaluation of the Efficacy and Safety of the Transcatheter Mitral Valve Repair System in Patients with Moderate and Above Degenerative Mitral Regurgitation at High Surgical Risk 109

On-X Life Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 110

On-X Mitral Heart Valve – Product Status 110

On-X Mitral Heart Valve – Product Description 110

On-X Mitral Valve-Low INR – Product Status 111

On-X Mitral Valve-Low INR – Product Description 111

Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 112

Masa Valve – Product Status 112

Masa Valve – Product Description 112

Peca Labs Inc – Ongoing Clinical Trials Overview 113

Masa Valve – MASA Valve Early Feasibility Study 114

Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 115

Prosthetic Heart Valve – Product Status 115

Prosthetic Heart Valve – Product Description 115

Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 116

Heart Valve – Product Status 116

Heart Valve – Product Description 116

Shanghai Aoliu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 117

Congenital Heart Valve Device – Product Status 117

Congenital Heart Valve Device – Product Description 117

Shanghai Hanyu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 118

ValveNeo – Product Status 118

ValveNeo – Product Description 118

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 119

External Mounted Bioprosthetic Heart Valve – Product Status 119

External Mounted Bioprosthetic Heart Valve – Product Description 119

Internal Mounted Bioprosthetic Heart Valve – Product Status 120

Internal Mounted Bioprosthetic Heart Valve – Product Description 120

Tissue Based Cardiac Valve – Product Status 120

Tissue Based Cardiac Valve – Product Description 120

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 121

Transapical Mitral Valve Delivery System – Product Status 121

Transapical Mitral Valve Delivery System – Product Description 121

Transeptal Mitral Valve Delivery System – Product Status 122

Transeptal Mitral Valve Delivery System – Product Description 122

Transfemoral Mitral Valve Delivery System – Product Status 122

Transfemoral Mitral Valve Delivery System – Product Description 123

Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 124

Percutaneous Heart Valve – Product Status 124

Percutaneous Heart Valve – Product Description 124

Symetis SA Pipeline Products & Ongoing Clinical Trials Overview 125

ACURATE TA LP Transapical Delivery System – Product Status 125

ACURATE TA LP Transapical Delivery System – Product Description 125

The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 126

LEAP Aortic Valve – Product Status 126

LEAP Aortic Valve – Product Description 126

LEAP Mitral Valve – Product Status 127

LEAP Mitral Valve – Product Description 127

LEAP Pulmonary Valve – Product Status 127

LEAP Pulmonary Valve – Product Description 128

LEAP Tricuspid valve – Product Status 128

LEAP Tricuspid valve – Product Description 128

Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 129

Next Generation Device For TAVI – Product Status 129

Next Generation Device For TAVI – Product Description 129

Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130

Optimum TAV Delivery Catheter – Product Status 130

Optimum TAV Delivery Catheter – Product Description 130

Precision 2 Catheter – Product Status 131

Precision 2 Catheter – Product Description 131

TRiCares SAS Pipeline Products & Ongoing Clinical Trials Overview 132

Topaz Tricuspid Valve Replacement (TTVR) System – Product Status 132

Topaz Tricuspid Valve Replacement (TTVR) System – Product Description 132

TRiCares SAS – Ongoing Clinical Trials Overview 133

Topaz Tricuspid Valve Replacement (TTVR) System – TRiCares Topaz Transfemoral Tricuspid Heart Valve Replacement System First In Human Trial 134

TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 135

Second Generation TTK-Chitra Heart valve – Product Status 135

Second Generation TTK-Chitra Heart valve – Product Description 135

University College London Pipeline Products & Ongoing Clinical Trials Overview 136

Percutaneous Heart Valve Delivery Device – Product Status 136

Percutaneous Heart Valve Delivery Device – Product Description 136

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 137

Polymeric Heart Valve – Product Status 137

Polymeric Heart Valve – Product Description 137

University of California Pipeline Products & Ongoing Clinical Trials Overview 138

Atrioventricular Heart Valves Delivery System – Product Status 138

Atrioventricular Heart Valves Delivery System – Product Description 138

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 139

Bileaflet Bioprosthetic Mitral Valve – Product Status 139

Bileaflet Bioprosthetic Mitral Valve – Product Description 139

Heart Valve Leaflets – Product Status 140

Heart Valve Leaflets – Product Description 140

Tubular Scaffold Heart Valves – Product Status 140

Tubular Scaffold Heart Valves – Product Description 141

Valve Insertion Device – Product Status 141

Valve Insertion Device – Product Description 141

University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 142

Polivalve – Product Status 142

Polivalve – Product Description 142

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 143

Prosthetic Valve – Product Status 143

Prosthetic Valve – Product Description 143

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 144

Replacement Heart Valve – Product Status 144

Replacement Heart Valve – Product Description 144

University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 145

Mechanical Aortic Prosthetic Valve Delivery Device – Product Status 145

Mechanical Aortic Prosthetic Valve Delivery Device – Product Description 145

University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 146

Peripheral Mitral Valve Delivery System – Product Status 146

Peripheral Mitral Valve Delivery System – Product Description 146

Sutureless Mitral Valve Replacement Device – Product Status 147

Sutureless Mitral Valve Replacement Device – Product Description 147

Thoracotomy Mitral Valve Delivery System – Product Status 147

Thoracotomy Mitral Valve Delivery System – Product Description 148

Transatrial Mitral Valve Delivery System – Product Status 148

Transatrial Mitral Valve Delivery System – Product Description 148

University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview 149

Infant Metallic Valve – Product Status 149

Infant Metallic Valve – Product Description 149

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 150

Ascending Aortic Prosthesis – Product Status 150

Ascending Aortic Prosthesis – Product Description 150

University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 151

Prostheses Heart Valve – Product Status 151

Prostheses Heart Valve – Product Description 151

ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 152

Pulmonic Pediatric Valve – Product Status 152

Pulmonic Pediatric Valve – Product Description 152

Vanguard System – Product Status 153

Vanguard System – Product Description 153

Vitality Exchangeable Valve System – Product Status 153

Vitality Exchangeable Valve System – Product Description 154

VXi Vanguard II – Product Status 154

VXi Vanguard II – Product Description 154

Vdyne LLC Pipeline Products & Ongoing Clinical Trials Overview 155

Tricuspid Regurgitation System – Product Status 155

Tricuspid Regurgitation System – Product Description 155

Vdyne LLC – Ongoing Clinical Trials Overview 156

Tricuspid Regurgitation System – Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation 157

Venus Haoyue Medtech Ltd Pipeline Products & Ongoing Clinical Trials Overview 158

Sutureless Aortic Valve – Product Status 158

Sutureless Aortic Valve – Product Description 158

Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview 159

Small Incision Surgical Valve – Product Status 159

Small Incision Surgical Valve – Product Description 159

VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 160

MR-Enhancing Percutaneous Heart Valve – Product Status 160

MR-Enhancing Percutaneous Heart Valve – Product Description 160

W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 161

GORE PV1 Device – Product Status 161

GORE PV1 Device – Product Description 161

Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 162

Xeltis Pulmonary Valve – Product Status 162

Xeltis Pulmonary Valve – Product Description 162

Xeltis AG – Ongoing Clinical Trials Overview 163

Xeltis Pulmonary Valve – Prospective, Non-randomized, Open Label Clinical Study to Assess the Safety of the Bioabsorbable Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction 164

Xeltis Pulmonary Valve – Prospective, Non-randomized, Pivotal Study to Assess the Safety and Efficacy of the Bioabsorbable Pulmonary Valved Conduit in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction 164

Glossary 191

Figures

Prosthetic Heart Valves – Pipeline Products by Stage of Development 16

Prosthetic Heart Valves – Pipeline Products by Segment 17

Prosthetic Heart Valves – Pipeline Products by Territory 18

Prosthetic Heart Valves – Pipeline Products by Regulatory Path 19

Prosthetic Heart Valves – Pipeline Products by Estimated Approval Date 20

Prosthetic Heart Valves – Ongoing Clinical Trials 21

Frequently asked questions

Prosthetic Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Prosthetic Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Prosthetic Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Prosthetic Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.